Anorexia nervosa (AN) can be terminal—and is in many cases. The Gaudiani et al. [1] paper proposing that we should consider if and how we should define ‘terminal AN’ has led to important discussions within our field, particularly giving individuals with lived experience an important platform to share their thoughts and concerns on this sensitive topic (e.g. [2,3,4,5]). Being a researcher without personal lived experience of AN, I have been reluctant to weigh in on the discussion as I would not be in the unenviable position of either a clinician or an individual with AN having to make decisions on ceasing treatment and pursuing end-of-life care if ‘terminal AN’ criteria were established. I am, however, in the unfortunate position of having lost a loved one to AN; my aunty died from the physical complications of AN in 2008, aged 35, after a long and severe course of the illness. Being open about my family history in my professional life means that since the Gaudiani et al. [1] paper was first published, I have been asked on countless occasions where I stand on the issue of defining ‘terminal AN’. As someone who tends to be vocal about various issues in our field (and likes to stir the pot to encourage scientific debate; see [6,7,8,9]), I find myself unable to form a strong opinion favouring either side of this argument. What I do feel strongly about though, is that we need to be having these discussions—and we need to do so in a respectful and considered way. This is a complex and sensitive issue that requires consideration from all perspectives, even when those perspectives do not alight with our own. In terms of my own opinion on the matter—through the lens of a researcher who sees individuals with AN across illness severities and across the spectrum of recovery, as well as having watched one of my favourite people in the world suffer a long and painful illness and death from AN—I can see both sides of the argument and my perspective falls somewhere in between.

While I believe that we need to be able to have open discussions regarding whether we define end-of-life care for AN, the terminology used to refer to ‘terminal AN’ is problematic. Unlike other medical illnesses which can directly lead to death, illness course is much more complex and varied for mental illnesses and are not terminal in the same sense. The feedback from individuals with lived experience has also been loud and clear that this terminology is not appropriate, and the concept of ‘terminal AN’ has the potential to cause harm [2,3,4,5]. These authors have provided strong and well-reasoned arguments identifying the many issues that would result if ‘terminal AN’ criteria were determined—which I wholeheartedly agree with—including submitting to the ambivalence that is often present in terms of treatment and recovery, losing hope that recovery is possible, and that they are not deserving of treatment. These perspectives are of particular importance as they not only come from people with lived experience of AN, but also from several individuals who would have met the ‘terminal AN’ criteria proposed by Gaudiani et al. [1] but were able to re-engage in treatment. This highlights the critical importance of incorporating the voice of lived experience in the work we do, and if end-of-life care criteria or guidelines are to be pursued, that they are co-developed with a diverse range of individuals with lived experience of AN including those with severe and long-standing illness who have re-engaged in treatment, as well as those who have not.

Despite disagreeing with the terminology used by Gaudiani et al. [1] regarding ‘terminal AN’, I do agree with the authors that we need guidance on end-of-life care in this space. The reality is, that despite best efforts, our treatments are not effective for many with AN, and several will sadly either die from the physical consequences of the illness or will take their own lives. While recovery is possible after even very long-standing illness [10], our field is nowhere near at the stage where we are able to identify who will and who will not respond to treatments—which makes establishing criteria for determining someone with ‘terminal AN’ virtually impossible. Internationally, there are efforts being made to improve treatments and consequent outcomes for individuals with AN. While I am hopeful that new and more effective treatments will be developed, research is slow-moving and we need to concurrently support those currently in need of end-of-life care. While it is imperative that we continue to provide hope to individuals with AN that they can recover despite the severity and length of their illness, we do also need to acknowledge that there are many who will die from the illness, and we need guidance on how to compassionately approach end-of-life care for these individuals. Defining criteria, however, is problematic given the rigid nature of employing categorical approaches. As such, it may be more appropriate to establish guidelines that provide (non-binding) recommendations and guidance. The establishment of any such guidelines should be undertaken collaboratively with diverse voices of those with lived experience, and if they are to be employed, to be administered cautiously on a case-by-case basis, and in deep consultation with the individual and their family. While we should always endeavour to pursue treatment and recovery, we also need to show compassion for those at every illness stage. Rarely discussed in the AN space is the concept of dignity of risk—i.e. giving individuals the right to make decisions for themselves, even when there may be concerns about their capacity to do so. Dignity of risk is applied widely throughout the aged care and disability sector, and while decision-making capacity may be considered to be reduced in some of these individuals, affording people the freedom to make decisions about their own lives is paramount. This concept challenges our very instinct to protect others from harm but may be a more compassionate approach, particularly if we can ensure that the individual is expressing their true wishes rather than their decisions being driven specifically by their AN. The traditional concept of dignity of risk involves taking ‘reasonable risks’ to improve dignity and quality of life, and it is important for us to understand how this concept may be extended to end-of-life care in AN and, critically, whether the concept resonates with individuals with AN or not.

Defining ‘terminal AN’—or more appropriately, end-of-life care—is an important topic that requires considerate, thoughtful and respectful discussion. I am thankful to Gaudiani et al. [1] for initiating the dialogue on this vital issue. Ultimately, Gaudiani et al. [1] argue for compassionate care for those who wish to end their life. While I have concerns with the terminology used and the proposal to establish criteria, I agree with the authors that clarity is needed on how to determine if end-of-life care is warranted and how to approach it if so. It is essential that if any guidelines on end-of-life care for AN are to be produced, that they are co-designed with those with lived experience to ensure that hope can still be maintained that recovery is possible irrespective of length or severity of illness; in addition to ensuring the voice of lived experience determines the content of any such guidelines. By taking a thoughtful, considerate and compassionate approach to end-of-life care, it does not mean that we need to lose hope, but that all individuals with AN are treated with the dignity and respect that they deserve. Despite my aunty being so unwell for such a long time, I don’t believe she would have pursued end-of-life care if it was offered to her—but I would have wanted her to be given the dignity to make that decision for herself.